Clinical Trial

Efficacy and Safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage

Study acronym: NESICH
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 10, 2024 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
To compare the efficacy and safety of neuroendoscopic hematoma removal and standard conservative treatment for patients with spontaneous supratentorial deep intracerebral hemorrhage.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-09-12; most recent amendment 2024-05-08.
Status change: Not Yet Recruiting → Recruiting 2023-03-28
Trial Details
NCT Number NCT05539859
Lead Sponsor Southwest Hospital, China
Conditions Intracerebral Hemorrhage Basal Ganglia
Enrollment 560 participants
Start Date 2022-11-18
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-05-10